Page last updated: 2024-09-05

tinuvin 770 and Disease Models, Animal

tinuvin 770 has been researched along with Disease Models, Animal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buccafusco, JJ; Hall, BJ; Pearson, LS1
Buccafusco, JJ; Hall, BJ; Pearson, LS; Terry, AV1

Other Studies

2 other study(ies) available for tinuvin 770 and Disease Models, Animal

ArticleYear
Effect of the use-dependent, nicotinic receptor antagonist BTMPS in the forced swim test and elevated plus maze after cocaine discontinuation in rats.
    Neuroscience letters, 2010, Apr-26, Volume: 474, Issue:2

    Topics: Analysis of Variance; Animals; Behavior, Animal; Cocaine; Decanoic Acids; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Male; Maze Learning; Nicotinic Antagonists; Piperidines; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Swimming

2010
The use-dependent, nicotinic antagonist BTMPS reduces the adverse consequences of morphine self-administration in rats in an abstinence model of drug seeking.
    Neuropharmacology, 2011, Volume: 61, Issue:4

    Topics: Animals; Behavior, Addictive; Decanoic Acids; Disease Models, Animal; Male; Morphine; Morphine Dependence; Nicotinic Antagonists; Piperidines; Rats; Rats, Wistar; Self Administration; Substance Withdrawal Syndrome

2011